抗精神病薬
□記事を途中から表示しています
[最初から表示]
^ 王立オーストラリア総合医学会 (2006-03), ⇒Medical care of older persons in residential aged care facilities (silver book), The Royal Australian College of General Practitioners, p. 32, ISBN 0-86906-212-3, ⇒http://www.racgp.org.au/your-practice/guidelines/silverbook/
^ アメリカ精神医学会 (September 2013). ⇒Five Things Physicians and Patients Should Question. Choosing Wisely (Report). ABIM Foundation.
^ ⇒QS53 - Anxiety disorders (Report). 英国国立医療技術評価機構. February 2014. Quality statement 3.
^ Bellack AS (July 2006). “Scientific and Consumer Models of Recovery in Schizophrenia: Concordance, Contrasts, and Implications”. Schizophrenia Bulletin 32 (3): 432?42. doi:10.1093/schbul/sbj044. PMC 2632241. PMID 16461575. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2632241/.
^ Mangrella M, Motola G, Russo F et al. (1998). “[Intensive hospital monitoring of adverse reactions to benzodiazepines and neuroleptic agents]” (Italian). Minerva Medica 89 (7?8): 293?300. PMID 9824992.
^ Healy 2009, p42. Psychiatric drugs explained 5th ED. Edinburgh : Elsevier Churchill Livingstone
^ Artaloytia, J. F. (March 2006). “Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of Placebo, Haloperidol, and Risperidone in Healthy Volunteers”. American Journal of Psychiatry 163 (3): 488?493. doi:10.1176/appi.ajp.163.3.488. PMID 16513871.
^ Weinmann, Stefan; Read, John; Aderhold, Volkmar (August 2009). “Influence of antipsychotics on mortality in schizophrenia: Systematic review”. Schizophrenia Research 113 (1): 1?11. doi:10.1016/j.schres.2009.05.018. PMID 19524406.
^ a b Joukamaa, M. (February 2006). ⇒“Schizophrenia, neuroleptic medication and mortality”. The British Journal of Psychiatry 188 (2): 122?127. doi:10.1192/bjp.188.2.122. PMID 16449697. ⇒http://bjp.rcpsych.org/content/188/2/122.full.
^ “ ⇒Public Health Advisory: Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances”. FDA (2005年4月11日). 2013年3月20日閲覧。
^ a b Glever, J (2008年). ⇒“Boxed Mortality Warning Added to Older Antipsychotics Given to Elderly Demented”. Medpage Today. ⇒http://www.medpagetoday.com/Psychiatry/AlzheimersDisease/9845 2009年4月24日閲覧。
^ Kales, Helen C.; Kim, Hyungjin Myra; Zivin, Kara; Valenstein, Marcia; Seyfried, Lisa S.; Chiang, Claire; Cunningham, Francesca; Schneider, Lon S. et al. (January 2011). ⇒“Risk of Mortality Among Individual Antipsychotics in Patients With Dementia”. The American Journal of Psychiatry 169 (1): 71?9. doi:10.1176/appi.ajp.2011.11030347. PMID 22193526. ⇒http://ajp.psychiatryonline.org/article.aspx?articleid=181225.
^ Schneider-Thoma J, Efthimiou O, Huhn M, et al. (August 2018). “Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials”. Lancet Psychiatry (8): 653?663. doi:10.1016/S2215-0366(18)30177-9. PMID 30042077.
^ Fourrier-Reglat, Annie (April 2012). “Antipsychotic Use and Myocardial Infarction in Older Patients With Treated Dementia”. Archives of Internal Medicine 172 (8): 648. doi:10.1001/archinternmed.2012.28. PMID 22450214.
^ Trifiro G, Gambassi G, Sen EF, Caputi AP, Bagnardi V, Brea J, Sturkenboom MC (April 2010). “Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study”. Annals of Internal Medicine 152 (7): 418?25, W139?40. doi:10.1059/0003-4819-152-7-201004060-00006. PMID 20368647.
^ a b Schizophrenia Drugs May Spur Subtle Brain Tissue Loss. Drugs.com.
^ Ho, Beng; Andreasen, Nancy C.; Ziebell, Stephen; Pierson, Ronald; Magnotta, Vincent (Feb. 2011). ⇒“Long-term antipsychotic treatment and brain volumes: a longtitudinal study of first-episode schizophrenia”. Archives of General Psychiatry 68 (2): 128?37. doi:10.1001/archgenpsychiatry.2010.199. PMC 3476840. PMID 21300943. ⇒http://archpsyc.ama-assn.org/cgi/reprint/68/2/128 2011年4月5日閲覧。.
^ lewis, David A (Feb. 2011). “Antipsychotic medications and brain volume: do we have a cause for concern?”. Archives of General Psychiatry 68 (2): 126?27. doi:10.1001/archgenpsychiatry.2010.187.
^ ⇒抗精神病薬による脳への負の影響。その1 灰白質への影響 場末Ｐ科病院の精神科医のblog
^ ⇒抗精神病薬による脳への負の影響。その2 白質への影響 場末Ｐ科病院の精神科医のblog
^ Dorph-Petersen, Karl-Anton; Pierri, Joseph N; Perel, James M; Sun, Zhuoxin; Sampson, Allan R; Lewis, David A (2005). “The Influence of Chronic Exposure to Antipsychotic Medications on Brain Size before and after Tissue Fixation: A Comparison of Haloperidol and Olanzapine in Macaque Monkeys”. Neuropsychopharmacology 30 (9): 1649?1661. doi:10.1038/sj.npp.1300710. ISSN 0893-133X.
^ Radua, J.; Borgwardt, S.; Crescini, A.; Mataix-Cols, D.; Meyer-Lindenberg, A.; McGuire, P.K.; Fusar-Poli, P. (November 2012). ⇒“Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication”. Neuroscience & Biobehavioral Reviews 36 (10): 2325?2333. doi:10.1016/j.neubiorev.2012.07.012. PMID 22910680. ⇒http://www.sciencedirect.com/science/article/pii/S014976341200125X.
^ Zonnenberg C, Bueno-de-Mesquita JM, Ramlal D, Blom JD (2017). “Hypothermia due to Antipsychotic Medication: A Systematic Review”. Front Psychiatry: 165. doi:10.3389/fpsyt.2017.00165. PMC 5594062. PMID 28936184. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594062/.
^ Ruchita Shah; Sandeep Grover; Uma Maheshwari; Natasha Kate; Nidhi Malhotra (2010). “Acute akathisia with quetiapine: A case report and review of literature”. Indian Journal of Pharmacology. PMC 2991706. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991706/.
^ Weston-Green, K; Huang XF, Lian JM, Deng C (May 2012). ⇒“Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels”. European Neuropsychopharmacology 22 (5): 364?73. doi:10.1016/j.euroneuro.2011.09.003. PMID 21982116. ⇒http://www.sciencedirect.com/science/article/pii/S0924977X11002185.
次ページ記事の検索おまかせリスト▼オプションを表示暇つぶしWikipedia
Size:240 KB
出典: フリー百科事典『ウィキペディア（Wikipedia）』
担当:undef